Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study systematically maps the...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study systematically maps the...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their...

In a recent Viewpoint in JAMA Oncology, a group of oncology ethicists and clinicians examine the ethical challenges surrounding “Right to Try”...

In a recent Viewpoint in JAMA Oncology, a group of oncology ethicists and clinicians examine the ethical challenges surrounding “Right to Try”...

Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results for patients with...

A new review from researchers at the Icahn School of Medicine at Mount Sinai is shedding light on how cancer vaccines are entering a new and exciting...

A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves...